Recent gene profiling studies have demonstrated that the PI3K/Akt/mTOR pathway is upregulated in MCL and evidence has also been provided suggesting that Akt and mTOR-dependent signaling may be constitutively active in MCL [52,53,54]. The gene discussed is AKT1; the disease is mantle cell lymphoma.